Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Marine-Lenhart Syndrome: Functional Autonomy and Malignancy Risk Are Distinct Diagnostic Dimensions.

Created on 18 Nov 2026

Authors

Shinichiro M Koga

Published in

European thyroid journal. Nov 18, 2026. Epub Nov 18, 2026.

Abstract

Marine-Lenhart syndrome (MLS), characterized by Graves' disease coexisting with autonomously functioning thyroid nodule (s), presents distinctive diagnostic and therapeutic challenges. Recent emphasis on thyroid scintigraphy has highlighted the potential "unmasking" of initially suppressed nodules. However, this phenomenon should not be interpreted as evidence that every initially cold nodule represents a latent autonomously functioning nodule, because scintigraphic appearance reflects functional status at a particular point in time and predictors of subsequent autonomous function remain incompletely defined. Moreover, functional autonomy and malignancy risk represent distinct diagnostic dimensions. Scintigraphy characterizes thyroid function but cannot establish histological benignity. Conversely, although hyperfunctioning nodules have a very low but non-zero risk of malignancy and routine cytological evaluation is generally not recommended, scintigraphic hyperfunction alone does not establish histological benignity. Ultrasonographic risk assessment remains complementary to functional imaging, and fine-needle aspiration should be considered when clinically appropriate, particularly in the presence of highly suspicious or discordant ultrasonographic findings or suspicious cervical lymph nodes. Similarly, observations that some patients require higher radioiodine activities or repeat treatment should not be equated with an established universal dosing strategy, given the predominantly case-based evidence underlying the MLS literature. Nuclear medicine imaging remains indispensable for functional characterization in MLS, but its interpretation should recognize "unmasking" as a changing functional phenotype rather than a definitive diagnostic endpoint.

PMID:
43049456
Bibliographic data and abstract were imported from PubMed on 18 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 11
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement